Oncology Research Today is a free monthly online journal that collates and summarizes the latest research about Oncology, including details on cancer, surgery, chemotherapy, radiotherapy.

Volume 1 (2005), Issue 3 (December)

1. The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005.
   Expert Opin Pharmacother, 6(16): 2907-21. [Abstract] [Full-text]
2. Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group.
   BMJ, 331(7528): 1295. [Abstract] [Full-text]
3. Developing an oncology portfolio of anticancer drugs: the experience of one pharmaceutical company.
   Zentralbl Gynakol, 127(6): 385-8. [Abstract] [Full-text]
4. Positron emission tomography: clinical applications in oncology. Part 1.
   Expert Rev Anticancer Ther, 5(6): 1079-94. [Abstract] [Full-text]
5. Clinical practice guidelines on antiemetics in oncology.
   Expert Rev Anticancer Ther, 5(6): 963-72. [Abstract] [Full-text]
6. Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group.
   J Clin Oncol, 23(35): 9001-7. [Abstract] [Full-text]
7. Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).
   Cancer Chemother Pharmacol, 57(2): 207-12. [Abstract] [Full-text]
8. Family centred decision making and non-disclosure of diagnosis in a South East Asian oncology practice.
   Psychooncology, 14(12): 1052-9. [Abstract] [Full-text]
9. Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center.
   Arch Intern Med, 165(22): 2639-43. [Abstract] [Full-text]
10. Bariatric surgery in the field of gynecological oncology.
    Int J Gynecol Cancer, 15(6): 1254-7. [Abstract] [Full-text]
11. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
    Cancer, 104(12): 2792-7. [Abstract] [Full-text]
12. Clinically unsuspected pulmonary embolism--an important secondary finding in oncology CT.
    Clin Radiol, 61(1): 81-5. [Abstract] [Full-text]
13. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.
    J Clin Oncol, 23(36): 9329-37. [Abstract] [Full-text]
14. Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study.
    J Clin Oncol, 23(36): 9179-86. [Abstract] [Full-text]
15. Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.
    J Clin Oncol, 23(36): 9097-104. [Abstract] [Full-text]
16. The clinical role of CT/PET in oncology: an update.
    Cancer Imaging, 5: S68-75. [Abstract] [Full-text]
17. What the clinician wants to know: radiation oncology perspective.
    Cancer Imaging, 5: S1-2. [Abstract] [Full-text]
18. Is tailored therapy feasible in oncology?
    Crit Rev Oncol Hematol, 57(1): 79-101. [Abstract] [Full-text]
19. Morphine, haloperidol and hyoscine N-butyl bromide combined in s.c. infusion solutions: compatibility and stability. Evaluation in terminal oncology patients.
    Int J Pharm, 307(2): 278-84. [Abstract] [Full-text]
20. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Gynecol Oncol, 100(1): 27-32. [Abstract] [Full-text]
21. A phase I trial of gemcitabine and topotecan in previously treated ovarian or peritoneal cancer: a Gynecologic Oncology Group study.
    Gynecol Oncol, 100(1): 111-5. [Abstract] [Full-text]
22. XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report.
    Blood, 107(1): 39-45. [Abstract] [Full-text]
23. Treatment of stage I, IIA, IIIA1 pediatric Hodgkin disease with doxorubicin, bleomycin, vincristine and etoposide (DBVE) and radiation: a Pediatric Oncology Group (POG) study.
    Pediatr Blood Cancer, 46(2): 198-202. [Abstract] [Full-text]
24. Phase II study of gemcitabine in children with relapsed acute lymphoblastic leukemia or acute myelogenous leukemia (ADVL0022): a Children's Oncology Group Report.
    Pediatr Blood Cancer, 46(2): 193-7. [Abstract] [Full-text]
25. Decision making in pediatric oncology: who should take the lead? The decisional priority in pediatric oncology model.
    J Clin Oncol, 24(1): 160-5. [Abstract] [Full-text]
26. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.
    J Clin Oncol, 24(1): 152-9. [Abstract] [Full-text]
27. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
    Cancer, 106(1): 188-95. [Abstract] [Full-text]
28. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.
    J Clin Oncol, 24(1): 36-44. [Abstract] [Full-text]
29. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    J Clin Oncol, 24(1): 190-205. [Abstract] [Full-text]

© 2005-2008 Oncology Research Today. All Rights Reserved.